Gilead Sciences

GSK’s Dovato Matches Efficacy of Gilead’s Biktarvy in Head-to-Head HIV Trial
BioSpace
Tue, 07/23/24 - 06:29 pm
GSK
Dovato
Gilead Sciences
Biktarvy
clinical trials
HUV
A new biotech tackling IBD joins a race against Lilly and Gilead for a promising pill
Pharma Voice
Thu, 07/18/24 - 11:12 am
Ensho Therapeutics
IBD
Gilead Sciences
Eli Lilly
Gilead’s CMO to depart next year
BioPharma Dive
Wed, 07/17/24 - 09:11 pm
Gilead Sciences
CMOs
biotech
Gilead set to unveil data from HIV/AIDS trials
Clinical Trials Arena
Wed, 07/17/24 - 12:15 pm
Gilead Sciences
HUV
AIDS
clinical trials
US government appeals Gilead's trial win in Truvada, Descovy patent fight
Fierce Pharma
Tue, 07/9/24 - 12:01 pm
Gilead Sciences
HIV
PrEP
Truvada
Descovy
patents
Gilead’s Trodelvy stumbles in late-stage trials but remains prized cancer asset
BioSpace
Mon, 07/1/24 - 11:39 am
Gilead Sciences
Trodelvy
bladder cancer
lung cancer
clinical trials
Gilead's long-acting HIV drug superior to daily pill Truvada in study
Reuters
Thu, 06/20/24 - 11:20 am
Gilead Sciences
lenacapavir
HIV
Truvada
Gilead’s Magrolimab ineffective, linked to increased risk of death in MDS patients
BioSpace
Mon, 06/17/24 - 11:39 am
Gilead Sciences
clinical trials
patient deaths
MDS
magrolimab
New EHA data reveal how badly Gilead's $4.9B bet on CD47 imploded
Fierce Biotech
Sun, 06/16/24 - 09:04 pm
Gilead Sciences
magrolimab
clinical trials
EHA
Gilead forks over $40M to settle thousands of claims in web of litigation over alleged delay of safer HIV meds
Fierce Pharma
Tue, 06/11/24 - 10:46 pm
Gilead Sciences
legal
HUV
Viread
Truvada
Vemlidy
Top ten biopharma R&D deals of 2024
Nature
Wed, 06/5/24 - 11:24 am
R&D
Novartis
Argo Biopharmaceutical
Roche
MOMA Therapeutics
Boehringer Ingelheim
Suzhou Ribo Life Science
Eli Lilly
Isomorphic Labs
Merus
Gilead Sciences
Novo Nordisk
Neomorph
AbbVie
Umoja Biopharma
Merck KGaA
Caris Life Sciences
Voyager Therapeutics
Gilead, Ipsen build the case for their PBC drugs at EASL
Pharmaphorum
Wed, 06/5/24 - 11:06 am
Gilead Sciences
Ipsen
primary biliary cholangitis
seladelpar
EASL
elafibranor
Vir pressures Gilead with hepatitis D cocktail showing early efficacy in phase 2
Fierce Biotech
Wed, 06/5/24 - 11:01 am
Vir Biotechnology
hepatitis D
clinical trials
Gilead Sciences
After two Big Pharma deals, Nimbus looks to keep the hits coming
Pharma Voice
Mon, 06/3/24 - 12:01 pm
Nimbus Therapeutics
Gilead Sciences
MASH
Takeda
'We're going to miss the next Keytruda': Lilly, Merck, Gilead and PhRMA CEOs talk IRA consequences
Fierce Pharma
Mon, 06/3/24 - 11:54 am
Merck
Eli Lilly
Gilead Sciences
innovation
Inflation Reduction Act
Keytruda
PhRMA
Gilead’s Trodelvy suffers double whammy as failed bladder cancer trial raises flag over early deaths
Fierce Pharma
Thu, 05/30/24 - 11:17 pm
Gilead Sciences
clinical trials
Trodelvy
bladder cancer
Biotech faces a reckoning: ‘We've lost our luster in cell therapies’
Fierce Biotech
Wed, 05/29/24 - 09:23 pm
cell therapy
Gilead Sciences
Kite Pharma
Gilead partnering with Cartography Biosciences to discover cancer therapies
Seeking Alpha
Tue, 05/28/24 - 10:40 am
Gilead Sciences
Cartography Biosciences
triple negative breast cancer
adenocarcinoma
Gilead's new liver disease med continues to deliver the goods ahead of FDA verdict
Fierce Biotech
Mon, 05/20/24 - 10:59 am
Gilead Sciences
CymaBay Therapeutics
seladelpar
liver disease
Biopharma M&A activity jumped 71% in Q1 2024
Medical Marketing and Media
Thu, 05/16/24 - 11:37 am
M&A
Novo Nordisk
Catalent
Gilead Sciences
CymaBay Therapeutics
AstraZeneca
Fusion Pharmaceuticals
JNJ
Ambrx

Pages